DE69301048D1 - Verbindungen, die Quinazoline und Tetrazolring enthalten, als Antitumorverbindungen - Google Patents
Verbindungen, die Quinazoline und Tetrazolring enthalten, als AntitumorverbindungenInfo
- Publication number
- DE69301048D1 DE69301048D1 DE69301048T DE69301048T DE69301048D1 DE 69301048 D1 DE69301048 D1 DE 69301048D1 DE 69301048 T DE69301048 T DE 69301048T DE 69301048 T DE69301048 T DE 69301048T DE 69301048 D1 DE69301048 D1 DE 69301048D1
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- compounds
- quinazoline
- tetrazole ring
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000000259 anti-tumor effect Effects 0.000 title abstract 2
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 2
- 125000003831 tetrazolyl group Chemical group 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 abstract 1
- 150000003246 quinazolines Chemical class 0.000 abstract 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929205320A GB9205320D0 (en) | 1992-03-11 | 1992-03-11 | Anti-tumour compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69301048D1 true DE69301048D1 (de) | 1996-02-01 |
| DE69301048T2 DE69301048T2 (de) | 1996-05-15 |
Family
ID=10711936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69301048T Expired - Fee Related DE69301048T2 (de) | 1992-03-11 | 1993-03-09 | Verbindungen, die Quinazoline und Tetrazolring enthalten, als Antitumorverbindungen |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5955463A (de) |
| EP (1) | EP0562734B1 (de) |
| JP (1) | JP3160111B2 (de) |
| KR (1) | KR100221011B1 (de) |
| AT (1) | ATE131823T1 (de) |
| AU (1) | AU659277B2 (de) |
| CA (1) | CA2090942C (de) |
| CZ (1) | CZ281811B6 (de) |
| DE (1) | DE69301048T2 (de) |
| DK (1) | DK0562734T3 (de) |
| ES (1) | ES2081178T3 (de) |
| FI (1) | FI108793B (de) |
| GB (2) | GB9205320D0 (de) |
| GR (1) | GR3018501T3 (de) |
| HK (1) | HK21297A (de) |
| HU (1) | HU211127A9 (de) |
| IL (1) | IL104984A (de) |
| NO (1) | NO301543B1 (de) |
| NZ (1) | NZ247122A (de) |
| RU (1) | RU2111209C1 (de) |
| TW (1) | TW223635B (de) |
| ZA (1) | ZA931447B (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9223352D0 (en) * | 1992-11-06 | 1992-12-23 | Ici Plc | Tricyclic compounds |
| GB9408936D0 (en) * | 1994-05-05 | 1994-06-22 | Cancer Res Inst | Anti-cancer compounds |
| US5804396A (en) * | 1994-10-12 | 1998-09-08 | Sugen, Inc. | Assay for agents active in proliferative disorders |
| US5837815A (en) * | 1994-12-15 | 1998-11-17 | Sugen, Inc. | PYK2 related polypeptide products |
| US5837524A (en) * | 1994-12-15 | 1998-11-17 | Sugen, Inc. | PYK2 related polynucleotide products |
| CA2222545A1 (en) * | 1995-06-07 | 1996-12-19 | Sugen, Inc. | Quinazolines and pharmaceutical compositions |
| US6716575B2 (en) | 1995-12-18 | 2004-04-06 | Sugen, Inc. | Diagnosis and treatment of AUR1 and/or AUR2 related disorders |
| US7119174B2 (en) | 1995-12-18 | 2006-10-10 | Sugen, Inc. | Diagnosis and treatment of AUR1 and/or AUR2 related disorders |
| US6818440B2 (en) | 1997-04-28 | 2004-11-16 | Sugen, Inc. | Diagnosis and treatment of alk-7 related disorders |
| US6228641B1 (en) | 1997-05-20 | 2001-05-08 | Sugen, Inc. | Diagnosis and treatment of PTP04 related disorders |
| US7115710B2 (en) | 1997-06-11 | 2006-10-03 | Sugen, Inc. | Diagnosis and treatment of PTP related disorders |
| US6342593B1 (en) | 1997-06-11 | 2002-01-29 | Sugen, Inc. | Diagnosis and treatment of ALP related disorders |
| US6388063B1 (en) | 1997-06-18 | 2002-05-14 | Sugen, Inc. | Diagnosis and treatment of SAD related disorders |
| US6495353B1 (en) | 1998-01-21 | 2002-12-17 | Sugen, Inc. | Human orthologues of wart |
| ATE302269T1 (de) | 1998-04-14 | 2005-09-15 | Sugen Inc | Ste20-verwandte proteinkinasen |
| US6235213B1 (en) * | 1998-05-18 | 2001-05-22 | Micron Technology, Inc. | Etching methods, methods of removing portions of material, and methods of forming silicon nitride spacers |
| US6861442B1 (en) | 1998-12-30 | 2005-03-01 | Sugen, Inc. | PYK2 and inflammation |
| GB9904275D0 (en) | 1999-02-24 | 1999-04-21 | Cancer Res Campaign Tech | Anti-cancer compounds |
| JP2003512838A (ja) | 1999-10-22 | 2003-04-08 | ファルマシア・アンド・アップジョン・カンパニー | ショウジョウバエｇタンパク質結合レセプター、核酸、およびそれに関連する方法。 |
| US6143776A (en) * | 2000-02-02 | 2000-11-07 | Sunesis Pharmaceuticals, Inc. | Tosylproline analogs as thymidylate synthase inhibitors |
| CA2458813C (en) | 2001-08-31 | 2011-11-01 | Btg International Limited | Anti-cancer cyclopenta[g]quinazoline compounds |
| DK1420809T3 (da) | 2001-08-31 | 2011-12-19 | Btg Int Ltd | Anvendelse af cyclopenta[G]quinazolinderivater til behandling af cancer |
| GB0317631D0 (en) * | 2003-07-28 | 2003-08-27 | Btg Int Ltd | Synthetic method |
| WO2007068895A1 (en) | 2005-12-15 | 2007-06-21 | Astrazeneca Ab | Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2065653B (en) * | 1979-12-19 | 1983-03-09 | Nat Res Dev | Anti-cancer quinazoline derivatives |
| ZA807909B (en) * | 1979-12-19 | 1981-12-30 | Nat Res Dev | Anti-cancer quinazoline derivatives |
| GB8513754D0 (en) * | 1985-05-31 | 1985-07-03 | Jones T R | Anti-cancer quinazoline derivatives |
| US5187167A (en) * | 1986-03-27 | 1993-02-16 | Imperial Chemical Industries Plc | Pharmaceutical compositions comprising quinazolin-4-one derivatives |
| GB8607683D0 (en) * | 1986-03-27 | 1986-04-30 | Ici Plc | Anti-tumor agents |
| US4725687A (en) * | 1986-04-28 | 1988-02-16 | Southern Research Institute | 5-methyl-5-deaza analogues of methotrexate and N10 -ethylaminopterin |
| GB8707053D0 (en) * | 1987-03-25 | 1987-04-29 | Ici Plc | Anti-tumour agents |
| US4857530A (en) * | 1987-11-03 | 1989-08-15 | Warner-Lambert Company | Substituted quinazolinones as anticancer agents |
| US4999424A (en) * | 1988-11-10 | 1991-03-12 | The Pennsylvania State University | GAR transformylase inhibitor |
| US5252573A (en) * | 1988-12-15 | 1993-10-12 | Imperial Chemical Industries Plc | Anti-tumor agents |
| GB8829296D0 (en) * | 1988-12-15 | 1989-01-25 | Ici Plc | Anti-tumour compounds |
| IL98167A0 (en) * | 1990-05-30 | 1992-06-21 | Ici Plc | Anti-tumour quinazoline derivatives,processes for their preparation and pharmaceutical compositions comprising them |
| US5145854A (en) * | 1991-11-27 | 1992-09-08 | Nair Madhavan G | 1-formyl-5,8,10-trideazafolates |
-
1992
- 1992-03-11 GB GB929205320A patent/GB9205320D0/en active Pending
-
1993
- 1993-02-25 AU AU33782/93A patent/AU659277B2/en not_active Ceased
- 1993-03-01 ZA ZA931447A patent/ZA931447B/xx unknown
- 1993-03-03 CA CA002090942A patent/CA2090942C/en not_active Expired - Fee Related
- 1993-03-08 IL IL104984A patent/IL104984A/en not_active IP Right Cessation
- 1993-03-08 CZ CZ93362A patent/CZ281811B6/cs not_active IP Right Cessation
- 1993-03-09 EP EP93301780A patent/EP0562734B1/de not_active Expired - Lifetime
- 1993-03-09 ES ES93301780T patent/ES2081178T3/es not_active Expired - Lifetime
- 1993-03-09 US US08/028,158 patent/US5955463A/en not_active Expired - Fee Related
- 1993-03-09 DK DK93301780.8T patent/DK0562734T3/da active
- 1993-03-09 AT AT93301780T patent/ATE131823T1/de not_active IP Right Cessation
- 1993-03-09 DE DE69301048T patent/DE69301048T2/de not_active Expired - Fee Related
- 1993-03-09 GB GB9304807A patent/GB2264946B/en not_active Expired - Fee Related
- 1993-03-10 FI FI931067A patent/FI108793B/fi active
- 1993-03-10 NO NO930881A patent/NO301543B1/no unknown
- 1993-03-10 KR KR1019930003536A patent/KR100221011B1/ko not_active IP Right Cessation
- 1993-03-10 RU RU93004793A patent/RU2111209C1/ru not_active IP Right Cessation
- 1993-03-11 NZ NZ247122A patent/NZ247122A/xx not_active IP Right Cessation
- 1993-03-11 JP JP05052593A patent/JP3160111B2/ja not_active Expired - Fee Related
- 1993-03-16 TW TW082101928A patent/TW223635B/zh active
-
1995
- 1995-06-14 HU HU95P/P00202P patent/HU211127A9/hu unknown
- 1995-12-21 GR GR950403484T patent/GR3018501T3/el unknown
-
1997
- 1997-02-27 HK HK21297A patent/HK21297A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69301048D1 (de) | Verbindungen, die Quinazoline und Tetrazolring enthalten, als Antitumorverbindungen | |
| MY129970A (en) | Hypolipidaemic compounds | |
| HU9401974D0 (en) | New intermediates for producing 9-[(substituted glicyl)-amido]-6-demetyl-6-deoxy-tetracyclines and pharmaceutical compositions containing them | |
| FI931888A (fi) | Kramploesande cykliska fruktopyranossulfiter -och sulfater | |
| ES2044836T3 (es) | Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene. | |
| NO307255B1 (no) | Nye forbindelser og antitumormidler | |
| HU9301866D0 (en) | Benzoxa-condensed-ring-compounds and medical preparatives containing these compounds and processes for production of these compounds and of pharmaceutical composition | |
| FI943508A0 (fi) | Pyridiinikarboksimidamidiyhdisteet ja niiden käyttö | |
| EA200400758A1 (ru) | Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат | |
| HUP9903526A2 (hu) | Pirimidinszármazékok és az ezeket tartalmazó gyógyszerkészítmények | |
| ATE4422T1 (de) | Substituierte 5-((7-chlor-4-chinolinyl)amino)-3(aminomethyl)-(1,1'-biphenyl)-2-ol-verbindungen verfahren zu ihrer herstellung; und die verbindungen enthaltende pharmazeutische zusammensetzungen. | |
| HUT71519A (en) | 7-substituted oxa- or azasteroid compounds and pharmaceutical compositions containing the same | |
| DE69208384T2 (de) | Fungizide Furanonderivate | |
| DE69409553T2 (de) | Zytotoxische Verbindungen | |
| ATE150970T1 (de) | Pharmazeutische zusammensetzungen die triazole derivate enthalten zur rektalen verabbrechung | |
| TH13163A (th) | อนุพันธ์ของกรดแอซิติค | |
| ES1024995U (es) | "espejo retrovisor para vehiculos automoviles" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |